Nike has cut its sales forecast from low double-digit growth to mid-single digits due to supply chain problems that threaten to crimp sales for the next few quarters.
The giant sportswear group expects its supply chain woes to lead to short-term inventory shortages.
The comments came as Nike reported profits of $1.9 billion in the quarter ending August 31, up 23 percent from the previous year.
Revenues climbed 16 percent to $12.2 billion but still fell short of analyst expectations by more than $200 million during the quarter ending August 31.
According to Nike CFO Matt Friend, they are dealing with a doubling of shipping times from its Asian manufacturing centers to North America, Europe, the Middle East, and Africa.
It also had to deal with COVID-19 induced local government restrictions that led to closures of its major factories in Vietnam and Indonesia and dented its sales in China.
Friend noted that poor shipping conditions have deteriorated further, hampered by port backlogs, rail congestion, and labor shortages.
He added that while Nike's manufacturing plants in Indonesia resumed operations, most of its operations in Vietnam have been dormant since the summer.
Nike expects to resume the Vietnam operations in October, resulting in a loss of 10 weeks of production.
Its shares fell 3.5 percent to $154.00 in after-hours trading.


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Australia’s major sports codes are considered not-for-profits – is it time for them to pay up?
Trump Urges Hall of Fame Induction for Roger Clemens Amid Renewed Debate
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
US Reviewing Visa Denial for Venezuelan Little League Team Barred from World Series
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Trump Threatens Stadium Deal Over Washington Commanders Name
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out 



